Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Daniel Keating has joined the firm’s corporate practice as a partner in the Washington, D.C., office. He will also be a member of the firm’s global generic pharmaceutical industry group.
Keating has more than 20 years of legal experience. He has focused his practice primarily on corporate and securities matters, including sophisticated domestic and international transactions. He has represented clients in mergers and acquisitions, public offerings, and financings, as well as related corporate governance matters. In particular, Keating has substantial experience representing multinational companies on cross-border M&A deals and complex commercial transactions.
Keating has worked with clients doing business in a broad range of industries. He has substantial experience working with clients in the technology, fintech, financial services, and life sciences sectors.
“Most of our clients do business not only in the U.S., but also internationally, so we know Dan’s expertise with both domestic and global transactions will complement the matters we already take on for companies and other entities we represent,” said Doug Clark, managing partner at Wilson Sonsini Goodrich & Rosati. “With Dan joining us in Washington, we continue to expand our East Coast corporate practice and strengthen our relationships with key clients, especially those in the global generics and financial industries. We look forward to working with Dan.”
Keating earned his J.D. from Georgetown University Law Center in 1996. He received his B.S. from Michigan State University in 1992, where he graduated summa cum laude. He is admitted to practice in the District of Columbia and New York.
“WSGR is a firm with an established, respected global reputation and brand for representing innovative technology and life sciences clients,” said Keating. “I’m excited about joining their corporate practice and, given my own expertise in the pharmaceuticals sector, I’m also looking forward to being a part of WSGR’s global generics industry team.”
Prior to joining WSGR, Keating was a corporate partner in an international law firm based in that firm’s Washington, D.C., office.
Source: www.wsgr.com
